The ESC Handbook on Cardiovascular Pharmacotherapy

Front Cover
Juan Carlos Kaski, Keld Per Kjeldsen
Oxford University Press, May 23, 2019 - Medical - 960 pages
This European Society of Cardiology (ESC) Handbook on Cardiovascular Pharmacotherapy has been developed by experts from the ESC Working Group on Cardiovascular Pharmacotherapy. Its recommendations are aligned with the ESC Clinical Practice Guidelines and based on the most recent scientific evidence in cardiovascular pharmacology and pharmacotherapy. The Handbook provides up-to-date information on pharmacotherapy for cardiovascular disease prevention, and treatment of cardiovascular disease, including ischaemic heart disease, heart failure, arrhythmias, and structural heart disease. The Handbook also deals with the important problems of cardiovascular pharmacotherapy in pregnancy and lactation, kidney insufficiency, and liver disease as well as focusing on major drug interactions, a topic of extreme importance in clinical practice. Two large sections of the book provide a comprehensive A-Z formulary of cardiac and non-cardiac pharmacological agents with practical and accessible information on the most important pharmacological aspects of these agents and their use in clinical practice.

The Handbook represents essential reading for cardiologists, general practitioners, internal medicine specialists, anaesthetists, clinical pharmacologists, geriatricians, obstetricians, and cardiovascular nurse consultants. Junior doctors and trainees in all these specialties are also likely to find this book of help.

The print edition comes with full access to the online version that will be updated at yearly intervals to keep it up to date.

 

What people are saying - Write a review

We haven't found any reviews in the usual places.

Contents

Section 2 Ischaemic heart disease
69
Section 3 Heart failure
141
Section 4 Arrhythmias
183
Section 5 Structural heart disease
259
Section 6 Management of cardiovascular disease in pregnancy and lactation and in the presence of comorbidities
315
Section 7 Major drug interactions
385
Section 8 Cardiovascular drugsfrom A to Z
411
Section 9 Noncardiac drugs affecting the heartfrom A to Z
811
Index
897
Copyright

Other editions - View all

Common terms and phrases

About the author (2019)


Juan Carlos Kaski, Cardiovascular Sciences Research Centre, St George's University of London, UK, Keld Per Kjeldsen, Department of Medicine (Division of Cardiology), Copenhagen University Hospital (Holbaek Hospital), Holbaek and Department of Health Science and Technology, The Faculty of Medicine, Aalborg University, Aalborg, Denmark

Professor Kaski is the Immediate Past Director of the Cardiovascular and Cell Sciences Research Institute, St George's, University of London. He is Doctor of Science, University of London, Fellow of the Royal College of physicians (London), the European Society of Cardiology, the American College of Cardiology and the American Heart Association, among over 20 other scientific societies worldwide. He is Deputy Editor in Chief, International Journal of Cardiology, Editor in Chief, European Cardiology Review and the Cardiovascular Pharmacotherapy book series, ISCP.

Professor Kjeldsen is author of over 200 papers and multiple books. Presenter of over 100 lectures nationally and internationally, he is Chairman at 45 scientific sessions. He has extensive experience as peer reviewer at scientific journals, from editorial boards, as chairman and organizer of meetings and congresses and as examiner of theses and research projects nationally and internationally. Teaching interests include Cardiology, cardiovascular pharmacology, and research methodology.

Bibliographic information